IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

Aims: Little is known about the prognosis of patients with massive pulmonary embolism (PE) and its risk of recurrent venous thromboembolism (VTE) compared with non-massive PE, which may inform clinical decisions. Our aim was to compare the risk of recurrent VTE, bleeding, and mortality after massive and non-massive PE during anticoagulation and after its discontinuation. Methods and results: We included all participants in the RIETE registry who suffered a symptomatic, objectively confirmed segmental or more central PE. Massive PE was defined by a systolic hypotension at clinical presentation (<90 mm Hg). We compared the risks of recurrent VTE, major bleeding, and mortality using time-to-event multivariable competing risk modeling. There were 3.5% of massive PE among 38 996 patients with PE. During the anticoagulation period, massive PE was associated with a greater risk of major bleeding (subhazard ratio [sHR] 1.72, 95% confidence interval [CI] 1.28–2.32), but not of recurrent VTE (sHR 1.15, 95% CI 0.75–1.74) than non-massive PE. An increased risk of mortality was only observed in the first month after PE. After discontinuation of anticoagulation, among 11 579 patients, massive PE and non-massive PE had similar risks of mortality, bleeding, and recurrent VTE (sHR 0.85, 95% CI 0.51–1.40), but with different case fatality of recurrent PE (11.1% versus 2.4%, P =.03) and possibly different risk of recurrent fatal PE (sHR 3.65, 95% CI 0.82–16.24). Conclusion: In this large prospective registry, the baseline hemodynamic status of the incident PE did not influence the risk of recurrent VTE, during and after the anticoagulation periods, but was possibly associated with recurrent PE of greater severity.

Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

Dentali F.;
2021-01-01

Abstract

Aims: Little is known about the prognosis of patients with massive pulmonary embolism (PE) and its risk of recurrent venous thromboembolism (VTE) compared with non-massive PE, which may inform clinical decisions. Our aim was to compare the risk of recurrent VTE, bleeding, and mortality after massive and non-massive PE during anticoagulation and after its discontinuation. Methods and results: We included all participants in the RIETE registry who suffered a symptomatic, objectively confirmed segmental or more central PE. Massive PE was defined by a systolic hypotension at clinical presentation (<90 mm Hg). We compared the risks of recurrent VTE, major bleeding, and mortality using time-to-event multivariable competing risk modeling. There were 3.5% of massive PE among 38 996 patients with PE. During the anticoagulation period, massive PE was associated with a greater risk of major bleeding (subhazard ratio [sHR] 1.72, 95% confidence interval [CI] 1.28–2.32), but not of recurrent VTE (sHR 1.15, 95% CI 0.75–1.74) than non-massive PE. An increased risk of mortality was only observed in the first month after PE. After discontinuation of anticoagulation, among 11 579 patients, massive PE and non-massive PE had similar risks of mortality, bleeding, and recurrent VTE (sHR 0.85, 95% CI 0.51–1.40), but with different case fatality of recurrent PE (11.1% versus 2.4%, P =.03) and possibly different risk of recurrent fatal PE (sHR 3.65, 95% CI 0.82–16.24). Conclusion: In this large prospective registry, the baseline hemodynamic status of the incident PE did not influence the risk of recurrent VTE, during and after the anticoagulation periods, but was possibly associated with recurrent PE of greater severity.
2021
WOS:000600028400001
2-s2.0-85097748881
hemorrhage; mortality; prognosis; pulmonary embolism; thrombolytic therapy
Blondon, M.; Jimenez, D.; Robert-Ebadi, H.; Del Toro, J.; Lopez-Jimenez, L.; Falga, C.; Skride, A.; Font, L.; Vazquez, F. J.; Bounameaux, H.; Monreal, M.; Prandoni, P.; Brenner, B.; Farge-Bancel, D.; Barba, R.; Di Micco, P.; Bertoletti, L.; Schellong, S.; Tzoran, I.; Reis, A.; Bosevski, M.; Maly, R.; Verhamme, P.; Caprini, J. A.; My Bui, H.; Adarraga, M. D.; Agud, M.; Aibar, J.; Aibar, M. A.; Alfonso, J.; Amado, C.; Arcelus, J. I.; Baeza, C.; Ballaz, A.; Barba, R.; Barbagelata, C.; Barron, M.; Barron-Andres, B.; Blanco-Molina, A.; Botella, E.; Camon, A. M.; Castro, J.; Caudevilla, M. A.; Cerda, P.; Chasco, L.; Criado, J.; de Ancos, C.; de Miguel, J.; Demelo-Rodriguez, P.; Diaz-Peromingo, J. A.; Diez-Sierra, J.; Diaz-Simon, R.; Dominguez, I. M.; Encabo, M.; Escribano, J. C.; Falga, C.; Farfan, A. I.; Fernandez-Capitan, C.; Fernandez-Reyes, J. L.; Fidalgo, M. A.; Flores, K.; Font, C.; Francisco, I.; Gabara, C.; Galeano-Valle, F.; Garcia, M. A.; Garcia-Bragado, F.; Garcia-Mullor, M. M.; Gavin-Blanco, O.; Gavin-Sebastian, O.; Gil-Diaz, A.; Gomez-Cuervo, C.; Gonzalez-Martinez, J.; Grau, E.; Guirado, L.; Gutierrez, J.; Hernandez-Blasco, L.; Jara-Palomares, L.; Jaras, M. J.; Jimenez, D.; Joya, M. D.; Jou, I.; Lacruz, B.; Lecumberri, R.; Lima, J.; Lobo, J. L.; Lopez-Brull, H.; Lopez-Jimenez, L.; Lopez-Miguel, P.; Lopez-Nunez, J. J.; Lopez-Reyes, R.; Lopez-Saez, J. B.; Lorente, M. A.; Lorenzo, A.; Loring, M.; Madridano, O.; Maestre, A.; Marchena, P. J.; Martin del Pozo, M.; Martin-Martos, F.; Martinez-Baquerizo, C.; Mella, C.; Mellado, M.; Mercado, M. I.; Moises, J.; Morales, M. V.; Munoz-Blanco, A.; Munoz-Guglielmetti, D.; Munoz-Rivas, N.; Nart, E.; Nieto, J. A.; Nunez, M. J.; Olivares, M. C.; Ortega-Michel, C.; Ortega-Recio, M. D.; Osorio, J.; Otalora, S.; Otero, R.; Parra, P.; Parra, V.; Pedrajas, J. M.; Pellejero, G.; Perez-Jacoiste, A.; Peris, M. L.; Pesantez, D.; Porras, J. A.; Portillo, J.; Reig, L.; Riera-Mestre, A.; Rivas, A.; Rodriguez-Cobo, A.; Rodriguez-Matute, C.; Rogado, J.; Rosa, V.; Rubio, C. M.; Ruiz-Artacho, P.; Ruiz-Gimenez, N.; Ruiz-Ruiz, J.; Ruiz-Sada, P.; Sahuquillo, J. C.; Salgueiro, G.; Samperiz, A.; Sanchez-Munoz-Torrero, J. F.; Sancho, T.; Siguenza, P.; Sirisi, M.; Soler, S.; Suarez, S.; Surinach, J. M.; Tiberio, G.; Torres, M. I.; Tolosa, C.; Trujillo-Santos, J.; Uresandi, F.; Usandizaga, E.; Valle, R.; Vela, J. R.; Vidal, G.; Vilar, C.; Villares, P.; Zamora, C.; Gutierrez, P.; Vazquez, F. J.; Vanassche, T.; Vandenbriele, C.; Verhamme, P.; Hirmerova, J.; Maly, R.; Salgado, E.; Benzidia, I.; Bertoletti, L.; Bura-Riviere, A.; Crichi, B.; Debourdeau, P.; Espitia, O.; Farge-Bancel, D.; Helfer, H.; Mahe, I.; Moustafa, F.; Poenou, G.; Schellong, S.; Braester, A.; Tzoran, I.; Amitrano, M.; Bilora, F.; Bortoluzzi, C.; Brandolin, B.; Ciammaichella, M.; Colaizzo, D.; Dentali, F.; Di Micco, P.; Giammarino, E.; Grandone, E.; Mangiacapra, S.; Mastroiacovo, D.; Maida, R.; Mumoli, N.; Pace, F.; Pesavento, R.; Pomero, F.; Prandoni, P.; Quintavalla, R.; Rocci, A.; Siniscalchi, C.; Tufano, A.; Visona, A.; Vo Hong, N.; Zalunardo, B.; Kalejs, R. V.; Maie, K.; Ferreira, M.; Fonseca, S.; Martins, F.; Meireles, J.; Bosevski, M.; Zdraveska, M.; Mazzolai, L.; Caprini, J. A.; Tafur, A. J.; Weinberg, I.; Wilkins, H.; Bui, H. M.
Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2123929
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact